Op-Eds Reform FDA advisory committees and put rare disease patients first Tricia Flanagan · June 11, 2026 11:00 am
Healthcare Pro-life activists skeptical of FDA abortion pill study Gabrielle M. Etzel · June 10, 2026 6:00 am
Healthcare Nutrition to be added to doctors’ licensing exams thanks to RFK Jr. push Gabrielle M. Etzel · June 8, 2026 4:12 pm
Op-Eds Fifty years of modern biotech, and an appetite for change Andrew Barnhill, Abe Sinay-Smith · June 8, 2026 10:00 am
Op-Eds It’s time for Congress to end Big Pharma’s war on generics David Marin · June 4, 2026 11:00 am
Op-Eds States already have pharmacy deserts. PBM reforms make it worse Naomi Lopez · June 3, 2026 10:00 am
Op-Eds The FDA is moving faster on psychedelics — now Washington must do more Peter Pitts · June 3, 2026 9:00 am
Fairness and Justice Section 232 tariffs on medical devices are a blunt instrument for a precision industry Charles Sauer · June 3, 2026 8:00 am
Op-Eds To fight the drug affordability crisis, Trump must crack down on middlemen Carl Schmid · June 3, 2026 6:00 am
Op-Eds Treatment for millions of Americans at stake in ‘skinny label’ Supreme Court case Kristina Acri · June 2, 2026 8:00 am
Op-Eds GLP-1 market shows how Americans can get lower drug prices Melanie Whittington, Joshua Kresh · June 1, 2026 11:00 am
Op-Eds
